Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment.

K, Kahnert; S, Andreas; C, Kellerer; JI, Lutter; T, Lucke; Ö, Yildirim; M, Lehmann; J, Seissler; J, Behr; M, Frankenberger; R, Bals; H, Watz; T, Welte; FC, Trudzinski; CF, Vogelmeier; P, Alter; RA, Jörres

doi:10.1038/s41598-022-05276-x

Public

Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment.

Shared by NobleBlocks on Jan 26, 2022 • 12:00 AM UTC

Authors:

Kahnert K

Andreas S

Kellerer C

Abstract

We studied whether in patients with COPD the use of metformin for diabetes treatment was linked to a pattern of lung function decline consistent with the hypothesis of anti-aging effects of metformin. Patients of GOLD grades 1-4 of the COSYCONET cohort with follow-up data of up to 4.5 y were include...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!